Walleye Trading Advisors »

Rapport Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $349k 11k 31.29
2025-09-30 $2.1M 70k 29.70

More positions owned by Walleye Trading Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Apple (AAPL)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Airbnb Com Cl A (ABNB)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Applied Materials (AMAT)
Spotify Technology S A SHS (SPOT)
Johnson & Johnson (JNJ)

View all positions for Walleye Trading Advisors

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Vanguard Capital Management
Polar Capital Holdings
Trv Gp Vi

View all funds holding Rapport Therapeutics